Skip to Content
You are currently on the new version of our website. Access the old version .
  • Review
  • Open Access

25 June 2013

15 Pages

MicroRNA Regulation in Renal Pathophysiology

and
1
Renal Division and Center for Investigation of Membrane Excitability Diseases, Washington University in St. Louis, 660 South Euclid Avenue, St. Louis, MO 63110, USA
2
Division of Pharmacology, PLA 85th Hospital, 1328 Hua Shan Road, Shanghai 20052, China
*
Author to whom correspondence should be addressed.
This article belongs to the Special Issue Regulation by non-coding RNAs 2013

Abstract

MicroRNAs are small, noncoding RNA molecules that regulate a considerable amount of human genes on the post-transcriptional level, and participate in many key biological processes. MicroRNA deregulation has been found associated with major kidney diseases. Here, we summarize current knowledge on the role of microRNAs in renal glomerular and tubular pathologies, with emphasis on the mesangial cell and podocyte dysfunction in diabetic nephropathy, the proximal tubular cell survival in acute kidney injury, the transport function of the thick ascending limb in Ca++ imbalance diseases, and the regulation of salt, K+ and blood pressure in the distal tubules. Identification of microRNAs and their target genes provides novel therapeutic candidates for treating these diseases. Manipulation of microRNA function with its sense or antisense oligonucleotide enables coordinated regulation of the entire downstream gene network, which has effectively ameliorated several renal disease phenotypes. The therapeutic potentials of microRNA based treatments, though promising, are confounded by major safety issues related to its target specificity, which remain to be fully elucidated.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.